1 / 14

Active and passive immunization

Active and passive immunization. Immunity to infectious microorganisms: 1- Active immunization *** natural processes *** artificial (vaccines) 2- Passive immunization *** natural processes (by transfer of maternal Abs across placenta to the fetus or by colostrum and milk

bookerd
Download Presentation

Active and passive immunization

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Active and passive immunization • Immunity to infectious microorganisms: 1- Active immunization *** natural processes *** artificial (vaccines) 2- Passive immunization *** natural processes (by transfer of maternal Abs across placenta to the fetus or by colostrum and milk *** artificial (antisera)

  2. Passive immunization • Conditions for use of passive immunization *deficiency in synthesis of Ab ** exposure or likely exposure to a disease *** infection by pathogens (botulism,tetanus,diphtheria,hepatitis,measles, rabies and also protection from poisonous snake ,insect bites). ****immediate protection to travelers or health care workers

  3. Cautions • Anti-isotype or allotype response

  4. Success of active immunization • If the infectious agent does not establish latency • Does not undergo any antigenic variation • Does not interfere with the host immune response • Infectious agent must be limited to human host

  5. Designing vaccines • Whole –organism vaccines *Attenuated viruses and bacteria ** inactivated or killed • Purified antigen vaccines * polysaccharide capsule ** Toxoid *** Recombinant proteins • DNA vaccines • Recombinant vector vaccines

  6. Whole –organism vaccines Attenuated vaccines

  7. Advantages and disadvantages • Provide prolonged immune system exposure • Increased immunogenicity • Production of memory cells • Single immunization • Inducing a humoral and cell mediated immunity • They elicit all the innate and adaptive immune responses • Live attenuated viral vaccines are usually more effective *Possibility that they will revert to a virulent form ** complications similar to those seen in the natural disease

  8. Whole –organism vaccines • inactivated or killed • **** چند بار تجويز آنها مورد نياز است ** ايمني هومورال را تحريك ميكنند احتمال غير فعال نشدن برخي از عوامل وجود دارد

  9. polysaccharide capsule • Inability to activate Th cells • May be poorly immunogenic in infants Conjugate the antigen to protein carrier to form conjugate vaccines: *Antigen vaccines Recombinant DNA vaccines (Hepatitis B ,HSV,foot and mouth disease virus and papiloma virus)

  10. Live viral vector vaccines * The Gene introduce into attenuated virus or bacteria * The attenuated organism as a vector ,replicating within the host * Expressing the gene product of the pathogen. • CMI and humoral immunity

  11. Recombinant vector vaccines

  12. DNA vaccines • Plasmid DNA encoding antigenic proteins is injected directly into the muscle of recipient • Muscle and dendritic cells take up the DNA and the Ag is expressed

  13. Advantages and disadvantages • Leading to humoral and cellular immunity • The encoded protein is expressed in its natural form • DNA vaccines cause prolonged expression of the Ag,which generates significant immunilogical memory. • Refrigeration is not required,lowers the cost and complexity of delivery • The same plasmid vector can be custom tailored to make a variety of proteins. • Eliciting an innate immune response

  14. Future of DNA vaccines • Malaria,AIDS,influenza and HSV • Future experimental trials of DNA vaccines will mix genes for antigenic proteins with those for cytokines that direct the immune response to the optimum pathway.

More Related